Literature DB >> 12460330

IGF-I in a normal population: relation to psychosocial factors.

Anna-Lena Unden1, Stig Elofsson, Sarah Knox, Moira S Lewitt, Kerstin Brismar.   

Abstract

OBJECTIVE: IGF-I has important actions on cell division, apoptosis, differentiation and metabolism, as well as on cell proliferation in vascular smooth muscle. Deficiency of GH, an important regulator of IGF-I, is associated with reduced well-being. IGF-I levels have been related to cognitive function in older individuals. The aim of the present study was to investigate the IGF-I concentrations in a normal population of men and women aged 20-74 years and to determine the influence of a variety of behavioural and psychosocial factors as well as metabolic factors on these concentrations.
DESIGN: Cross-sectional study. PATIENTS: The study group consisted of 408 randomly selected people who had answered a questionnaire concerning health care utilization and quality of life that was administered to a random sample of 4200 people over age 17 from the northwestern region of greater Stockholm in 1995. Thirty-four men and 34 women were randomly selected from the age group 20-24 and from each 10-year age group between the ages of 25-75 years. Seventy-one per cent of the 408 people invited to come in for an examination agreed to attend, making a total sample size of 288 people. MEASUREMENTS: A medical examination was performed and blood drawn in the morning after subjects had been fasting overnight. Before the examination, they were asked to fill out a questionnaire concerning lifestyle and psychosocial factors.
RESULTS: The distribution of IGF-I was positively skewed, but using logarithmically transformed IGF-I, a more symmetrical distribution was obtained. A linear inverse correlation was found between logarithmically transformed IGF-I levels and age which explained more than 40% of the variation in men and women. Linear correlation analysis between IGF-I and different parameters of health and disease, lifestyle and psychosocial factors, resulted in several significant correlations most of which disappeared after controlling for age. In the younger age group (20-44) there were positive correlations between IGF-I and psychosocial factors representing quality of life and psychological well-being. In the middle age group (45-59) higher IGF-I levels were related to better physical health, higher education and higher concentrations of lipoprotein Lp(a). In the older age group (over 59 years) higher levels of low-density lipoprotein-cholesterol (LDL-C) and lower levels of SHBG were associated with higher IGF-I levels.
CONCLUSION: In a randomly selected (nondisease) population, IGF-I concentrations show a consistent decrease with age in both men and women, accompanied by different association patterns relevant to disease risk. Levels are related to psychosocial parameters in the younger age group and metabolic impairment associated with increased cardiovascular risk in the older age groups. We speculate on the relative roles of age and cohort differences in rearing conditions in determining these differences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460330     DOI: 10.1046/j.1365-2265.2002.01671.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population.

Authors:  G Aimaretti; M Boschetti; G Corneli; V Gasco; D Valle; M Borsotti; A Rossi; A Barreca; L Fazzuoli; D Ferone; E Ghigo; F Minuto
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 2.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

3.  The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women.

Authors:  H Salminen; M Sääf; H Ringertz; L E Strender
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

Review 4.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

5.  Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.

Authors:  Ole Torffvit; Majid Kalani; Jan Apelqvist; Björn Eliasson; Jan W Eriksson; Kerstin Brismar; Gun Jörneskog
Journal:  Biochem Res Int       Date:  2012-02-12

6.  Maladaptive and adaptive emotion regulation through music: a behavioral and neuroimaging study of males and females.

Authors:  Emily Carlson; Suvi Saarikallio; Petri Toiviainen; Brigitte Bogert; Marina Kliuchko; Elvira Brattico
Journal:  Front Hum Neurosci       Date:  2015-08-26       Impact factor: 3.169

Review 7.  Sex differences in type 2 diabetes: focus on disease course and outcomes.

Authors:  Lisa Arnetz; Neda Rajamand Ekberg; Michael Alvarsson
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-16       Impact factor: 3.168

8.  Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Authors:  Urban Alehagen; Peter Johansson; Jan Aaseth; Jan Alexander; Kerstin Brismar
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

9.  IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes.

Authors:  Emma Eklund; Anton Hellberg; Bo Berglund; Kerstin Brismar; Angelica Lindén Hirschberg
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-16       Impact factor: 5.555

10.  Effects of protein-rich nutritional supplementation and bisphosphonates on body composition, handgrip strength and health-related quality of life after hip fracture: a 12-month randomized controlled study.

Authors:  Lena Flodin; Tommy Cederholm; Maria Sääf; Eva Samnegård; Wilhelmina Ekström; Amer N Al-Ani; Margareta Hedström
Journal:  BMC Geriatr       Date:  2015-11-17       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.